Zalutumumab plus best supportive care versus best supportive care alone in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck after failure of platinum-based chemotherapy: an open-label, randomised phase 3 trial (Q37850188)
Jump to navigation
Jump to search
scientific article published on 04 March 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Zalutumumab plus best supportive care versus best supportive care alone in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck after failure of platinum-based chemotherapy: an open-label, randomised phase 3 trial |
scientific article published on 04 March 2011 |
Statements
1 reference
Zalutumumab plus best supportive care versus best supportive care alone in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck after failure of platinum-based chemotherapy: an open-label, randomised phase 3 trial (English)
1 reference
Jean-Pascal Machiels
1 reference
Somasundaram Subramanian
1 reference
Agnes Ruzsa
1 reference
Gabor Repassy
1 reference
Igor Lifirenko
1 reference
Annika Flygare
1 reference
Tina Nielsen
1 reference
Steen Lisby
1 reference
Paul M J Clement
1 reference
Per Sørensen
1 reference
4 March 2011
1 reference
1 reference
Identifiers
1 reference